Simplex Trading’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-77
| Closed | – | – | 8500 |
|
|
2024
Q3 | $0 | Sell |
77
-290
| -79% | -$1.37K | ﹤0.01% | 8470 |
|
|
2024
Q2 | $1K | Buy |
367
+98
| +36% | +$735 | ﹤0.01% | 8416 |
|
|
2024
Q1 | $2K | Buy |
+269
| New | +$1.48K | ﹤0.01% | 8361 |
|
|
2023
Q2 | – | Sell |
-12,226
| Closed | -$507K | – | 8953 |
|
|
2023
Q1 | $605K | Buy |
12,226
+11,489
| +1,559% | +$333K | ﹤0.01% | 3080 |
|
|
2022
Q4 | $18K | Buy |
737
+724
| +5,569% | +$27.1K | ﹤0.01% | 6961 |
|
|
2022
Q3 | $0 | Hold |
13
| – | – | ﹤0.01% | 9887 |
|
|
2022
Q2 | $0 | Sell |
13
-146
| -92% | -$6.58K | ﹤0.01% | 9943 |
|
|
2022
Q1 | $7K | Buy |
159
+146
| +1,123% | +$7.17K | ﹤0.01% | 9144 |
|
|
2021
Q4 | $0 | Hold |
13
| – | – | ﹤0.01% | 10468 |
|
|
2021
Q3 | $0 | Hold |
13
| – | – | ﹤0.01% | 9761 |
|
|
2021
Q2 | $0 | Hold |
13
| – | – | ﹤0.01% | 10022 |
|
|
2021
Q1 | $0 | Hold |
13
| – | – | ﹤0.01% | 8802 |
|
|
2020
Q4 | $0 | Sell |
13
-47
| -78% | -$6.4K | ﹤0.01% | 8325 |
|
|
2020
Q3 | $15K | Buy |
+60
| New | +$12.3K | ﹤0.01% | 6541 |
|
|
2019
Q3 | – | Sell |
-1,065
| Closed | -$62.8K | – | 7237 |
|
|
2019
Q2 | $63K | Buy |
1,065
+766
| +256% | +$44.6K | ﹤0.01% | 4654 |
|
|
2019
Q1 | $19K | Buy |
299
+149
| +99% | +$8.48K | ﹤0.01% | 5744 |
|
|
2018
Q4 | $7K | Buy |
150
+139
| +1,264% | +$6.85K | ﹤0.01% | 6035 |
|
|
2018
Q3 | $0 | Sell |
11
-182
| -94% | -$11K | ﹤0.01% | 7395 |
|
|
2018
Q2 | $11K | Buy |
193
+157
| +436% | +$9.24K | ﹤0.01% | 6277 |
|
|
2018
Q1 | $1K | Sell |
36
-36
| -50% | -$1.81K | ﹤0.01% | 5544 |
|
|
2017
Q4 | $4K | Buy |
+72
| New | +$4.31K | ﹤0.01% | 4645 |
|
|
2017
Q3 | – | Sell |
-12
| Closed | -$777 | – | 5890 |
|
|
2017
Q2 | $0 | Sell |
12
-502
| -98% | -$30.9K | ﹤0.01% | 6082 |
|
|
2017
Q1 | $32K | Buy |
514
+310
| +152% | +$16.1K | ﹤0.01% | 2772 |
|
|
2016
Q4 | $7K | Buy |
+204
| New | +$7.07K | ﹤0.01% | 4021 |
|
|
2015
Q4 | – | Sell |
-119
| Closed | -$4K | – | 5389 |
|
|
2015
Q3 | $4K | Buy |
+119
| New | +$5.59K | ﹤0.01% | 4110 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 5168 |
|
Other funds holding BCLI
LWM
HF
WCG
TSS
IC
Simplex Trading's BCLI Position: Q4 2024 in Review
Simplex Trading sold out of BRAINSTORM CELL THERAPUTC (BCLI) in Q4 2024, closing a stake of 77 shares.
Simplex Trading first reported a position in BCLI in Q3 2015 and held it in 25 quarters. The position peaked at $605K in Q1 2023. 34 funds tracked by Wall St. Rank hold BCLI as of Q4 2024.
- Simplex Trading reported no remaining BRAINSTORM CELL THERAPUTC position as of Q4 2024 after selling out during the quarter.
- Simplex Trading sold 77 BRAINSTORM CELL THERAPUTC shares in Q4 2024.
- Simplex Trading first reported a position in BRAINSTORM CELL THERAPUTC in Q3 2015 and held it in 25 quarters.
- Simplex Trading's BRAINSTORM CELL THERAPUTC position peaked at $605K in Q1 2023.
- 34 funds tracked by Wall St. Rank held BRAINSTORM CELL THERAPUTC as of Q4 2024.
Based on Simplex Trading's 13F filing for Q4 2024, filed 11 Feb 2025.